(4-isothiocyanatophenyl)(2-methoxyphenyl)amine, 95.0%, 10g

Methyl 3,4-diamino-5-bromobenzoate, 95.0%, 5g

2-[5-(Furan-2-yl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzoic acid, 95.0%, 1g

2-Oxo-3H-pyrimidine-4-carboxylic acid, 95.0%, 10g

tert-Butyl 2-chloro-7,8-dihydropyrido[3,2-d]pyrimidine-5(6H)-carboxylate, 95%, 1g

3,3-dimethyl-1-(3-nitro-1H-pyrazol-1-yl)butan-2-one, 95.0%, 2g

3,8-Dibromo-1,10-phenanthroline-5,6-dione, 97.0%, 250mg

Oxion Inverso OX.2453-PLPHF with LWD Plan fluarex 10x and plan phase fluarex 20x/40x objectives, 4-position filter blocks and XY cross table

1-(2-Methoxyphenyl)cyclopropane-1-carboxylic acid, 95.0%, 1g

2-(2-Hydroxyethyl)quinoline, 95.0%, 10g

D-Alanine ethyl ester hydrochloride, 98.0%, 10g

4,8-Disulfonaphthalene-2,6-dicarboxylic acid, 97%, 5g

Methyl 2-(1-(7-methyl-2-morpholino-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl)ethylamino)benzoate, 95%, 1g